Person

Ian T. Meredith

Formerly EVP Global Chief Med Officer, Boston Scientific

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$591K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 28, 2022BSXSale6,588$43.68$288K
Dec 28, 2021BSXSale7,018$43.21$303K

SEC reporting-owner ID (CIK) 1693920 · all filings on EDGAR

Ian T. Meredith | USBoard